Expert opinion on the introduction of the meningococcal B (4CMenB) vaccine in the EU/EEA

[摘要] The multicomponent meningococcal B (4CMenB) vaccine Bexsero for the prevention of serogroup B invasive meningococcal disease (SgB IMD) has been available in the European Union/European Economic Area (EU/EEA) since 2013. Meningococcal serogroup B (SgB) is the most common cause of IMD in all age g...

[发布日期] 2018-12-10 [发布机构] Publications office of the European Union

[效力级别] infant mortality [学科分类] 自然科学（综合）